Details for New Drug Application (NDA): 065489
The generic ingredient in CLARITHROMYCIN is clarithromycin. There is one drug master file entry for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
Summary for 065489
| Tradename: | CLARITHROMYCIN |
| Applicant: | Aurobindo |
| Ingredient: | clarithromycin |
| Patents: | 0 |
Pharmacology for NDA: 065489
| Mechanism of Action | Cytochrome P450 3A Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
Medical Subject Heading (MeSH) Categories for 065489
Suppliers and Packaging for NDA: 065489
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065489 | ANDA | Major Pharmaceuticals | 0904-6872 | 0904-6872-04 | 30 BLISTER PACK in 1 CARTON (0904-6872-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
| CLARITHROMYCIN | clarithromycin | TABLET;ORAL | 065489 | ANDA | PD-Rx Pharmaceuticals, Inc. | 43063-823 | 43063-823-20 | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-823-20) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Jul 25, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Jul 25, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
